Virus inactivation composition composed of particle group

A virus inactivating composition using a diluted acid eluate from weathered granite effectively targets and inactivates SARS-CoV2 and influenza viruses in the oral and nasal cavities and closed spaces, addressing the ineffectiveness of current disinfectants and skin irritation issues.

JP2024157062AInactive Publication Date: 2024-11-07SHIMANISHI KAKEN
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2021134419
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2021-07-13
Publication Date
2024-11-07
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Current disinfectants are ineffective in inactivating the new coronavirus (SARS-CoV2) and influenza virus in the oral cavity, nasal cavity, and closed spaces, and cause skin irritation and other adverse effects when used frequently.

Method used

A virus inactivating composition comprising a group of particles formed from a diluted aqueous solution of an acid eluate from weathered granite, containing various metal and non-metal salts, is atomized into specific particle sizes for use in the nasal cavity, oral cavity, and closed spaces to inactivate viruses.

Benefits of technology

The composition effectively inactivates viruses in the oral and nasal cavities and closed spaces without causing skin irritation, while being non-toxic to human cells and maintaining a safe pH level.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024157062000001_ABST
    Figure 2024157062000001_ABST
Patent Text Reader

Abstract

To provide a virus inactivation composition composed of a group of atomized particles from a properly diluted aqueous solution of an acid-elution liquid, with metal salt as the primary component, in order to inactivate the novel coronavirus and influenza virus.SOLUTION: A virus inactivation composition, intended for inactivating viruses, comprises a group of particles of a liquid with an average diameter of 1 μm-500 μm that floats and / or falls in a gas, or is transported by means of negative or positive pressure. The liquid comprises a diluted aqueous solution of a leachate comprising a large number of metal salts prepared by subjecting igneous rocks, including granite, contact metamorphic rocks, and / or their weathered forms, to leaching with inorganic and / or organic acids.SELECTED DRAWING: Figure 2
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a virus inactivating composition comprising a group of particles that inactivates the novel coronavirus (SARS-CoV2) and influenza viruses that cause infections of the nasal cavity, oral cavity, and upper respiratory tract, and relates to a virus inactivating composition comprising a group of particles that is used for oral disinfection, body washing, and air purification in closed spaces. [Background technology]

[0002] The history of humans and viruses began at the birth of mankind, and has caused countless pandemics throughout history, bringing misfortune to humanity. In recent years, the infection mechanisms of some of the viruses that cause these pandemics have gradually come to light.

[0003] For example, the measles virus, which causes infectious diseases, has various routes of infection, including droplet nuclei infection (airborne infection), droplet infection, and contact infection, and is highly contagious. Once inside the human body, the measles virus grows mainly in the lymphatic tissue throughout the body, which is responsible for immunity, causing a strong immune suppression state, which leads to the aggravation of infections caused by other bacteria. Poliovirus also infects motor nerve cells in the spinal cord, brain stem, and cerebral cortex, causing paralysis of the lower limbs. The AIDS virus (HIV) infects receptors in immune cells, causing immunodeficiency. Herpes virus (HSV) is caused by close contact with an individual who is actively releasing the virus, and after infection, it lies dormant in nerve ganglia, from which it periodically emerges and causes symptoms.

[0004] On the other hand, the infection routes of the novel coronavirus (SARS-CoV2) and influenza viruses are said to be droplet and contact infections. In particular, part of the novel coronavirus (SARS-CoV2) that enters through the nasal cavity or oral cavity attaches to the oral mucosa in the nasal cavity or oral cavity, and from there enters the trachea and bronchi and reaches the alveoli. The spike protein of influenza viruses and novel coronavirus (SARS-CoV2) acts as a key, attaching to a keyhole called a receptor on the cell surface and infecting the virus. Since the receptors are located in the cells of the nasal cavity, oral cavity, and airway epithelium, it is said that respiratory epithelial cells are infected first. In addition, there are reports that the novel coronavirus directly infects cells of the gums, inside the cheeks, and tongue, and proliferates in the mouth.

[0005] Patent Document 1 discloses a bactericidal disinfectant made of a mineral-containing solution derived from mica-based minerals. The mineral-containing solution exerts a bactericidal and disinfecting effect by oxidizing action caused by the generation of OH radicals, and describes its bactericidal and disinfecting effect against Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella enterica, Salmonella typhi, and human immunodeficiency virus. [Prior art documents]

[0006] [Patent Document 1] Japanese Patent Application Publication No. 7-238004 Summary of the Invention [Problem to be solved by the invention]

[0007] As mentioned above, unlike the measles virus, poliovirus, AIDS virus, and herpes virus, the novel coronavirus (SARS-CoV2) and influenza virus first infect and multiply in respiratory epithelial cells or directly in the oral cavity, so there is a strong desire to inactivate the virus in the oral cavity.

[0008] Although the prior art documents describe the inactivation effect against measles virus, human immunodeficiency virus, herpes virus, and polio virus, there is no mention of the influenza virus or the new coronavirus.

[0009] As mentioned above, each type of virus has its own unique properties, and the inactivating agents used to combat these viruses also differ depending on the type of virus. The prior art documents do not suggest inactivation of influenza viruses or the new coronavirus.

[0010] In addition, even if the measles virus, polio virus, AIDS virus, and herpes virus attach to the body and enter the human body through the nasal or oral cavity, once infection has begun, germicides and disinfectants do not come into direct contact with the viruses, and there is no description of a prescription for inactivating the invading viruses.

[0011] Currently, the commonly used germicides and disinfectants include alcohols such as ethyl alcohol and isopropyl alcohol, phenols such as phenol, cresol, and chlorhexidine, halogens such as chlorine gas, sodium hypochlorite, iodine / potassium iodine solution, and tincture of iodine, as well as alkylating agents such as formaldehyde and glutaraldehyde, oxidizing agents such as hydrogen peroxide and potassium permanganate, and surfactants such as soap.

[0012] Among these, ethyl alcohol, sodium hypochlorite, povidone-iodine, glutaraldehyde, and potassium permanganate are used for antiviral purposes, and povidone-iodine and hydrogen peroxide are effective for disinfecting the oral cavity and pharynx.

[0013] Of these, povidone-iodine can be used in the oral cavity and pharynx, and its 7% solution and diluted solutions are reported to be effective in inactivating the new coronavirus (SARS-CoV2). However, one gargle contains 14-28 mg of iodine. The amount of iodine absorbed into the body is unclear, but the upper limit for iodine intake per day is set at 3 mg, making it difficult to gargle multiple times a day. Exceeding this standard for a long period of time is said to cause thyroid abnormalities.

[0014] As things stand, no disinfectant consisting of liquid particles has been found that can act directly on the oral cavity, nasal cavity, pharynx, and larynx to inactivate the novel coronavirus that proliferates in the oral cavity, which serves as a kind of incubator, and attaches to and proliferates there.

[0015] On the other hand, there is a need to address contact infection, which is one of the routes of infection. Disinfection of viruses, sputum, and feces attached to the body, as well as disinfection of parts that people touch, is generally done by spraying or injecting ethyl alcohol or hypochlorous acid liquid onto hands or objects, but as the frequency of use increases, the sebum components on the skin also decrease at the same time, causing rough skin. No liquid particle group composition has been found that solves this problem, does not have a negative effect on the skin, and is effective in inactivating influenza viruses and the new coronavirus (SARS-CoV2).

[0016] Furthermore, the new coronavirus (SARS-CoV2) floating as an aerosol in enclosed spaces is also considered to be a source of infection. One way to deal with this is to open the windows to let in fresh air, but this is difficult in spaces without windows, in the cold of midwinter, or on rainy days. No disinfectant or method using liquid particles that can inactivate viruses floating in such enclosed spaces has yet been discovered.

[0017] The present invention aims to provide a virus inactivation composition consisting of a particle group of an appropriately diluted aqueous solution of an acid eluate mainly composed of a metal salt in order to inactivate the novel coronavirus (SARS-CoV2) and influenza viruses, and further to provide an oral disinfectant consisting of a particle group based on an appropriate formulation for inactivating viruses that have come into contact with or entered the human body via the nasal or oral cavity, a disinfectant consisting of a particle group that inactivates viruses attached to the body or objects that the body comes into contact with, and a disinfectant consisting of a particle group that inactivates viruses floating in closed spaces, and a method for using the same. [Means for solving the problem]

[0018] The present invention relates to rocks formed when magma cools and solidifies, and their parent rocks are granite, peridotite, gabbro, diorite, komatiite, basalt, andesite, rhyolite, and granite porphyry.The weathered bodies and powders of these rocks are dissolved in inorganic or organic acids to elute various myrrhotic components, and the resulting mineral solution is diluted with drinking water to a specific range and atomized into particles with a specific average diameter, which has led to the discovery of the inactivation of the new coronavirus (SARS-CoV2) and influenza viruses.

[0019] Among the above mineral solutions, a mineral solution obtained by using weathered eroded granite containing vermiculite, a mica-based mineral, as the raw material and eluting it with an inorganic acid having a high elution rate is preferred because it does not contain arsenic, lead, mercury, chromium, or cadmium, and contains a variety of metal salts including iron, magnesium, potassium, manganese, calcium, aluminum, zinc, silicon, sodium, copper, phosphorus, titanium, nickel, cobalt, molybdenum, lithium, vanadium, tungsten, rubidium, germanium, selenium, and barium as metal components, as well as phosphorus as a non-metallic salt.

[0020] Inorganic acids that can be used include sulfuric acid and hydrochloric acid, and organic acids include acetic acid, citric acid, L-tartaric acid, succinic acid, lactic acid, etc., but inorganic acids that relatively easily dissolve mineral components are preferred, and sulfuric acid is most preferred because of its bactericidal and antiviral effects.

[0021] The virus inactivating composition consisting of the particle group of the present invention inactivates viruses by contacting them, but the mechanism is not fully understood due to the complex interactions between various metal components and acids, and although it is not an established inactivation theory, it is believed that various transition metals and nonmetals produce metal salts and nonmetal salts with acids, and various metals form complex salts, which results in the production of hydroxyl radical ·OH, which has strong oxidizing power. Hydroxyl radical ·OH has an unstable electronic state as oxygen, so it has a strong ability to pull out electrons from surrounding substances, i.e., oxidizing power, and is therefore thought to act directly on viruses, but on the other hand, hydroxyl radical ·OH is generated in the process of various reactions in the body, and its strong oxidizing power acts as a disinfectant against viruses and is necessary for maintaining immune function.

[0022] The raw material is weathered eroded granite, and the eluate containing various metal salts and nonmetal salts eluted with sulfuric acid has a strong acidity of 0.1 to 2.0, but since it forms complexes with a large number of various metal components, it does not cause chemical burns to the skin or cell epithelium. However, while this eluate has a great effect in inactivating viruses, the strong acidity acts on the taste sensors in the oral cavity and causes strong irritation, so the eluate needs to be diluted with drinking water to be used as an oral disinfectant.

[0023] Furthermore, when inactivating viruses that have adhered to the skin of the body or to objects that the body comes into contact with, the eluate has a strong inactivating effect, but due to its high oxidizing power it can cause discoloration and deterioration of the object, so the eluate must be diluted with drinking water.

[0024] That is, in the present invention, when a virus inactivating composition that inactivates the novel coronavirus (SARS-CoV2) is used as an oral disinfectant targeting the novel coronavirus, the virus inactivating composition is diluted 80 to 800 times with drinking water. This diluted virus inactivating composition is atomized to form a particle group having an average diameter of 0.1 μm to 100 μm, preferably 1 μm to 10 μm, and the particle group is sprayed into the nasal cavity or oral cavity or inhaled from the nasal cavity or oral cavity to inactivate the novel coronavirus (SARS-CoV2) attached to the mucous membrane of the nasal cavity or oral cavity and proliferated in the oral cavity.

[0025] In particular, if inhaled through the nasal cavity or oral cavity, the diluted aqueous solution of the virus inactivating composition is atomized, and the particles are carried along with oxygen-containing gas from the trachea to the bronchi and then to the alveoli, where they come into contact with the novel coronavirus (SARS-CoV2), inactivating not only the virus that remains in the nasal cavity and oral cavity, but also the virus that has attached to the deeper airways.

[0026] When used as an oral disinfectant targeting influenza viruses, the virus inactivating composition is diluted 800 to 5000 times with drinking water. This diluted virus inactivating composition is atomized to form particle groups with an average diameter of 0.1 μm to 100 μm, preferably 1 μm to 10 μm, and the particle groups are sprayed into the nasal cavity or oral cavity or inhaled from the nasal cavity or oral cavity to inactivate influenza viruses attached to the mucous membranes of the nasal cavity or oral cavity, thereby solving the problem.

[0027] Furthermore, when used as a disinfectant to inactivate the novel coronavirus (SARS-CoV2) and / or influenza viruses floating in closed spaces and purify the air, the virus inactivating composition is diluted with drinking water by a ratio of 50 to 4,000, and then atomized into particles with an average diameter of 0.1 μm to 500 μm, preferably 1 μm to 100 μm. The particle group is released into closed spaces such as rooms, restaurants, theaters, halls, baths, and the inside of cars, where it comes into contact with and inactivates the novel coronavirus (SARS-CoV2) and / or influenza viruses floating in aerosols, thereby solving the problem.

[0028] When targeting the novel coronavirus attached to the body and / or parts of the body, or medical equipment used for treatment, the virus inactivating composition is diluted 10 to 4,000 times, and this diluted virus inactivating composition is atomized into particles with an average diameter of 0.1 μm to 500 μm, preferably 1 μm to 100 μm, and the solution is solved by spraying a disinfectant that inactivates the attached novel coronavirus (SARS-CoV2) and / or influenza virus onto parts of the body, the skin-facing side of a sanitary mask, or medical equipment in a medical setting. Effect of the Invention

[0029] The virus inactivating composition of the present invention is excellent in inactivating the new coronavirus (SARS-CoV2) and influenza virus, is non-toxic to human cells, and is safe. The disinfectant is diluted at an appropriate ratio for each virus and atomized into particles having an average diameter of 0.1 μm to 100 μm, preferably 1 μm to 10 μm. The disinfectant is sprayed into the nasal cavity or oral cavity or inhaled from the nasal cavity or oral cavity to inactivate viruses that have attached and proliferated in the nasal cavity or oral cavity. If inhaled from the nasal cavity or oral cavity, the diluted aqueous solution of the virus inactivating composition is atomized, so the particle group is sent from the trachea to the bronchi and further to the alveoli together with oxygen-containing gas, and by coming into contact with the virus, it can inactivate the virus not only remaining in the nasal cavity or oral cavity but also attached to the airway deeper inside.

[0030] Furthermore, by releasing a group of particles with an average diameter of 0.1 μm to 500 μm at a specific dilution ratio into a closed space such as a room, theater, hall, bath, or car, the particles will come into contact with and inactivate the new coronavirus (SARS-CoV2) and / or influenza viruses floating in the closed space as aerosols, thereby purifying the air in the closed space.

[0031] In addition, it is a particle group with an average diameter of 0.1 μm to 500 μm at a specific dilution ratio, and by spraying it on parts of the body, the skin side of a sanitary mask, or medical equipment in a medical setting, it can inactivate the novel coronavirus (SARS-CoV2) and / or influenza virus that have adhered to it. [Brief description of the drawings]

[0032] [Figure 1] Dilution ratio and pH value of elution solution [Diagram 2] Virus reduction rate of each sample compared to the control [Diagram 3] The viral infectivity of the present invention when the viral infectivity of the control is set to 100 DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0033] Figure 1 shows the pH value of the elution solution measured for each dilution ratio, and the values ​​plotted on a logarithmic graph in order to find the appropriate dilution ratio of the elution solution suitable for the new coronavirus (SARS-CoV2) and influenza viruses. As shown in Figure 1, diluted aqueous solutions with a dilution ratio of 50 or less have a pH < 1.0, which is stronger than the sourness of lemon juice, which has a pH of around 2.5, and feels more sour and stimulating than lemon juice. On the other hand, at a dilution ratio of 4000, the pH is ≒ 3, and the diluted aqueous solution is less sour than lemon juice.

[0034] Five subjects took diluted solutions of different dilution ratios into their mouths, and the sourness and level of irritation felt by each subject was recorded. The diluted solutions were then left in the mouths and the subjects were checked at regular intervals to see if they could tolerate the acidic taste and level of irritation.

[0035] The diluted solutions were taken into the oral cavity at dilution ratios of 50, 80, 150, 400, 800, 1600, and 3200, and their sourness and irritation were evaluated.

[0036] As a result, it was found that when used as an oral disinfectant, a dilution ratio of 80 times or more is appropriate, based on the degree of sourness and irritation felt when taken into the oral cavity.

[0037] When targeting the new coronavirus, a diluted aqueous solution with a dilution ratio of less than 80 times kills the virus in a short time with a high probability, but the acidity and irritation felt in the oral cavity are strong, and spraying or inhaling the particle group of the diluted aqueous solution into the nasal cavity or oral cavity makes one feel uncomfortable, so it cannot be used practically. In addition, when spraying or inhaling the particle group of the diluted aqueous solution with a dilution ratio of more than 800 times into the nasal cavity or oral cavity, the feeling of discomfort is small, but the virus death rate is reduced and the inactivation effect is reduced. Therefore, the appropriate dilution ratio of the eluate as an oral disinfectant for the new coronavirus is 80 to 800 times, and from the viewpoint of discomfort and inactivation effect, the dilution ratio is preferably 120 to 500 times.

[0038] In the case of the new coronavirus, depending on the purpose of use, for example, in the case of infected individuals, a diluted aqueous solution of 80 times or more and close to 80 times is preferable, while in the case of non-infected individuals for the purpose of preventing infection, a dilution ratio of not more than 800 times and close to 800 times should be selected.

[0039] When targeting influenza viruses, a 2000-fold diluted aqueous solution can kill the virus in one second. When using oral disinfectants on a daily basis to prevent infection, a 4000-fold diluted aqueous solution with less acidity and irritation is also effective. Therefore, the appropriate dilution ratio of the eluate as an oral disinfectant for the new coronavirus is 800 to 4000 times, and preferably 1500 to 3000 times.

[0040] Disinfectants are released into closed spaces such as rooms, restaurants, theaters, halls, baths, and cars, and purify the air in the closed spaces by coming into contact with and inactivating the new coronavirus (SARS-CoV2) and / or influenza viruses floating in the closed spaces as aerosols. Since the density of particle groups in closed spaces does not become as high as that when oral disinfectants are applied to the nasal cavity or oral cavity, the appropriate range is particle groups with an average diameter of 0.1 μm to 100 μm when diluted with an aqueous solution at a dilution ratio of 50 to 4,000.

[0041] When a disinfectant is released to purify the air, droplets containing viruses are suspended at an extremely low density. In order to increase the probability that the particle group will come into contact with the droplets, it is preferable to give each particle that composes the particle group an electric charge opposite to that of the droplets. In general, droplets are often positively charged, so in that case it is desirable for each particle to be negatively charged.

[0042] On the other hand, when the target is disinfection of viruses, sputum, and feces attached to the body, or even parts that people touch, there is no need to consider acidity or irritation, so the dilution ratio can be set to a wider range than oral disinfectants, and an aqueous solution diluted 10 to 4000 times can be used. If the dilution is less than 10 times and is closer to the elution solution, it is difficult to apply because the skin may feel irritated due to the oxidation effect, and the disinfectant sprayed on the skin side of the sanitary mask may feel strange on the lips or cheeks. Also, if the dilution exceeds 4000 times, the inactivation effect against viruses decreases, which is not preferable.

[0043] The drinking water used in the dilution solution is not particularly limited as long as it is drinkable water, but in addition to tap water, spring water, and the like, distilled water, physiological saline, or when the taste and irritation of the diluted acid is strong, fruit juice, sweeteners, and natural flavors may be added to mitigate this.

[0044] The atomized particle group according to the present invention is a particle group that floats and / or falls in a gas, and the gas contains oxygen at a concentration of 21% to 70%. The gas referred to here is the air, which contains 21% oxygen and 79% nitrogen. In the case of a person infected with the new coronavirus, an artificial ventilator is attached to assist breathing of a person who has difficulty inhaling or has a low oxygen concentration in the blood. The artificial ventilator uses a gas that is a mixture of 22% to 70% oxygen and 30% to 78% nitrogen, and the virus inactivating composition of the atomized particle group of the present invention can be applied to this gas.

[0045] The particle group of the present invention is atomized to a size of an average diameter of 0.1 μm to 500 μm. In the case of a disinfectant for intraoral use, the particle group is sprayed or inhaled or exhaled by breathing, so it is necessary for the particle group to be fine particles suspended in the gas, and an average diameter of 0.1 μm to 100 μm, and more preferably 0.1 μm to 10 μm, is required. .

[0046] On the other hand, when inactivating viruses that are attached to the body or objects that the body touches, the particles are not suspended in the air, but are instead misted, jetted or sprayed onto the palm of the hand or object, and the average diameter should be in the range of 0.1 μm to 500 μm. EXAMPLES

[0047] (Virus inactivation evaluation) Weathered eroded granite containing vermiculite, a mica-based mineral, was used as the raw material, and the raw material and inorganic acid solution were added in a weight ratio of 4:3-4, heated to 80 degrees and stirred for several hours, and then filtered to produce an eluate containing sulfates, oxides, and complex salts of metals and nonmetals. The inorganic acid used was 25% and the sulfuric acid was 25%. The obtained eluate was diluted 150 times with drinking water, and the obtained oral disinfectant for inactivating the new coronavirus of the present invention was used as a test subject to evaluate its virus inactivation performance by the following method.

[0048] Control: Virus solution with 0 min reaction time Reference: Tap water Virus: Novel human coronavirus (SARS-CoV2 WK-521) Viral titer (undiluted): 3.6 x 10 4 TCID 50 / mL Cell: Vero cell Test overview: The sample was mixed with a virus solution, and after the reaction time, the virus solution was collected and used to infect cells to measure the amount of infectious virus.

[0049] Virus preparation: 3.0 × 10 Vero cells 5 After adjusting the cell / mL, 10 mL was added to 75 cm 337 0 C. After 1 day of incubation in a 5% CO2 incubator, 5 ~10 6 TCID 50 100 μL of SARS-CoV2 was inoculated and cultured for 3 days, and the TCID 50 The virus titer was measured according to the method. Prepare cells: 1.0 x 10 Vero cells 5 After adjusting the concentration to cells / mL, the cells were seeded in 100 μwells of a 96-well plate and cultured for one day in an incubator at 37°C with a CO2 concentration of 5%. Preparation of test specimen: 975 μL of test specimen was seeded onto a 247-well plate.

[0050] Reaction of the virus with the specimen: 25 μL of the virus solution was mixed with the specimen and allowed to react. The reaction time was 1 minute, and then 100 μL of the virus mixture was added to 900 μL of serum-free DMEM medium to stop the reaction.

[0051] Addition to Vero cells and incubation: The diluted solution in the test sample preparation was inoculated into the cells prepared in the virus preparation step, 100μL / well, 3 wells per test sample and reaction time. After incubation for 1 day in an incubator at 37°C with a CO2 concentration of 5%, the amount of infectious virus was measured and the antiviral activity of each test sample was evaluated.

[0052] The results are shown in Table 1 and shown as a bar graph in Figure 3. That is, when the virus infectivity of the control was set to 100, the virus infectivity in each sample at a reaction time of 0 minutes was confirmed to have decreased to 0.6% after 1 minute.

[0053] The virus reduction rate of each sample compared to the control is shown in Table 2, and a bar graph is shown in Figure 2. That is, the oral disinfectant for inactivating the new coronavirus of the present invention was confirmed to reduce the virus infectivity by 99.4% after 1 minute compared to the reaction time of 0 minutes.

[0054] [Table 1]

[0055] [Table 2] EXAMPLES

[0056] The same eluate as in Example 1 was diluted 2000-fold with drinking water, and the resulting oral disinfectant for inactivating influenza viruses of the present invention was used as a test subject to evaluate its virus inactivation performance by the following method.

[0057] Control: Virus solution with 0 min reaction time Virus: Influenza virus H1N1 A / PR / 8·34 Cells: MDCK cells (canine kidney cells) Test method: After dispensing 1.08 mL of the influenza virus inactivating oral disinfectant into a tube, dilute it with phosphate buffer (PBS) at 5-10 x 10 5 0.12 mL of influenza virus solution adjusted to pfu / mL was mixed and stirred to prepare the test solution.

[0058] The test solution was left to stand at room temperature and reacted. Immediately after, and every 1 and 5 minutes, the solution was collected from the test solution and mixed with 1.08 mL of Dulbecco's modified Eagle medium containing 0.2% bovine serum. Dilution with 0.2% FBS-DMEM medium was repeated several times to create a 10-fold serial dilution series, and 1 mL / well of the 10-fold serial dilution solution was dropped onto the host cells prepared in advance and infected for 1 hour at 37°C and 5% CO2. After virus infection, the cell supernatant was replaced with 0.8% oxoid agar solution, and the cells were cultured for 2 days at 37°C and 5% CO2, fixed and stained with 5% glutaraldehyde solution, and the virus infection titer was measured based on the measurement data of the number of plaques formed.

[0059] As a result, it was confirmed that the oral disinfectant for influenza viruses of the present invention, which was prepared by diluting the eluate 2000 times, inactivated 99.988% or more of the viruses immediately after application. The results are shown in Table 3.

[0060] [Table 3] EXAMPLES

[0061] (Cytotoxicity test) A cytotoxicity evaluation was conducted to confirm that the oral disinfectant for inactivating the new coronavirus of the invention used in Example 1 is not toxic to cells.

[0062] The "reaction between virus and specimen" test carried out in Example 1 was carried out using 25 μL of serum-free DMEM instead of the virus solution, and the solution that came into contact with the specimen was adjusted to evaluate cytotoxicity. The enzyme activity that reduces the MTT dye to formazan dye in the cells is optically measured. As a result, if the number of cells decreases due to death or other reasons, the amount of luminescence decreases.

[0063] 1.0 × 10 Vero cells 5 After adjusting the concentration to cella / mL, the solution was seeded on a 96-well plate and cultured for one day in an incubator at 37°C with a CO2 concentration of 5%. 975 μL of each specimen was seeded on a 24-well plate. 25 μL of serum-free DMEM was mixed with the specimen and reacted for one minute, the reaction was stopped, and 10-fold and 100-fold diluted solutions were seeded on the cultured Vero cells in 100 μL / well, 3 wells per specimen, and cultured for one day at 37°C under 5% CO2. 10 μL of MTT solution was added to each well, and the color reaction was carried out for 2 hours at 37°C under 5% CO2, and 100 μL of solubilization solution was added to each well, and the absorbance value at 595 nm was measured using a microplate reader.

[0064] The results are shown in Table 4. From Table 4, it was confirmed that the oral disinfectant for the new coronavirus of the present invention is not toxic to cells that come into contact with the solution.

[0065] [Table 4] EXAMPLES

[0066] Five subjects experienced the appropriate dilution ratio of the COVID-19 oral disinfectant, and when they took it into their mouths, they felt a sense of sourness and irritation. Each subject then rated the sourness on a five-rank scale, as shown in Table 5.

[0067] [Table 5] EXAMPLES

[0068] The eluate obtained in Example 1, in which weathered eroded granite containing vermiculite was dissolved in sulfuric acid, was diluted 150 times with drinking water, and atomized by ultrasonic vibration energy generated by an ultrasonic vibrator to obtain particle groups having a particle distribution with an average diameter of 2 μm. The obtained particle groups could be smoothly inhaled without turning into droplets when taken into the nasal cavity or oral cavity by inhalation. EXAMPLES

[0069] The eluate obtained in Example 1 by dissolving weathered eroded granite containing vermiculite in sulfuric acid was diluted 2000 times with drinking water, and atomized by ultrasonic vibration energy generated by an ultrasonic vibrator to produce a particle group with a particle distribution of an average diameter of 4 μm. When the obtained particle group was sprayed into the air, it was confirmed that it remained suspended for a long time. EXAMPLES

[0070] The eluate obtained in Example 1, obtained by dissolving weathered eroded granite containing vermiculite in sulfuric acid, was diluted 50 times with drinking water, and was sprayed onto the palms of the hands from the nozzle under pressure from a sprayer container and then rubbed both hands together for 30 seconds. This proved to be an ideal disinfectant.

Claims

1. A virus inactivating composition characterized in that it is a group of liquid particles with an average diameter of 1 μm to 500 μm that float and / or fall in a gas, or move due to negative pressure or pressure, said liquid being a diluted aqueous solution of an eluate containing a large number of metal salts eluted from igneous rock, typically granite, contact metamorphic rock, and / or weathered bodies thereof, with inorganic acids and / or organic acids, and that inactivates viruses.

2. The virus inactivating composition according to claim 1, characterized in that the liquid is a diluted aqueous solution of an eluate containing metal salts obtained by eluting weathered granite with sulfuric acid, the metals constituting the metal salts containing six or more metals selected from iron, magnesium, aluminum, potassium, zinc, barium, copper, nickel, titanium, calcium, manganese, sodium, cobalt, lithium, silicon, molybdenum, vanadium, tungsten, rubidium, germanium and selenium, or all of these, and further containing phosphorus as a non-metallic component.

3. The virus inactivating composition according to claims 1 or 2, characterized in that the virus is a novel coronavirus (SARS-CoV2) or an influenza virus.

4. The virus inactivating composition is a particle group having an average diameter of 0.1 μm to 100 μm, which consists of a diluted aqueous solution obtained by diluting the eluate with drinking water by 80 times or more and 800 times or less, and is inhaled through the nasal cavity and / or oral cavity to inactivate the novel coronavirus (SARS-CoV2) that has adhered to the lungs from the nasal cavity, oral mucosa, and / or airways. The disinfectant for novel coronavirus (SARS-CoV2) according to any one of claims 1 and 2, characterized in that the virus inactivating composition is a particle group having an average diameter of 0.1 μm to 100 μm, which consists of a diluted aqueous solution obtained by diluting the eluate with drinking water by 80 times or more and 800 times or less, and is inactivated through the nasal cavity and / or oral cavity to inactivate the novel coronavirus (SARS-CoV2) that has adhered to the lungs

5. The oral disinfectant for influenza according to any one of claims 1 and 2, characterized in that the virus inactivating composition is a particle group having an average diameter of 0.1 µm to 100 µm, which is composed of a diluted aqueous solution obtained by diluting the eluate with drinking water by 800 times or more and 4000 times or less, and which inactivates influenza viruses that have attached to the lungs from the nasal cavity, oral mucosa and / or airways by inhaling the composition through the nasal cavity or oral cavity and reaching the alveoli through the trachea and bronchi.

6. The virus inactivating composition is a particle group having an average diameter of 0.1 μm to 500 μm in a diluted aqueous solution obtained by diluting the eluate with drinking water by 50 times or more and 4000 times or less, and is released into a closed space such as a room, a restaurant, a theater, a hall, a bathhouse, or the inside of a car, and purifies the air in the closed space by coming into contact with and inactivating the novel coronavirus (SARS-CoV2) and / or influenza viruses suspended as aerosol in the closed space. The air purifying disinfectant according to any of claims 1 to 3.

7. The disinfectant according to any one of claims 1 to 3, wherein the virus inactivating composition is a particle group having an average diameter of 0.1 μm to 500 μm after diluting the eluate with drinking water by 10 times or more and 4,000 times or less, and is sprayed onto a part of the body, the skin-facing side of a sanitary mask, or medical equipment in a medical setting to inactivate attached novel coronavirus (SARS-CoV2) and / or influenza viruses.

8. The method for inactivating the novel coronavirus (SARS-CoV2) according to claim 4, characterized in that the eluate is diluted with drinking water by 80 times or more and 800 times or less, then atomized into particles having an average diameter of 0.1 μm to 100 μm, and inhaled through the nasal cavity and / or oral cavity, thereby inactivating the novel coronavirus (SARS-CoV2) that has adhered to the nasal cavity, oral mucosa, and trachea through the alveoli.

9. The method for inactivating influenza viruses according to claim 5, characterized in that the eluate is diluted with drinking water by 800 to 4000 times, then atomized into particles having an average diameter of 0.1 μm to 100 μm, and inhaled through the nasal cavity and / or oral cavity, thereby inactivating influenza viruses that have adhered to the nasal cavity, oral mucosa, and trachea through the alveoli.

10. The method for inactivating SARS-CoV2 and / or influenza viruses according to claim 6, further comprising the steps of: diluting the eluate with drinking water by 50 to 4,000 times; atomizing the eluate into particles having an average diameter of 0.1 μm to 500 μm; releasing the particles into a closed space such as a room, a restaurant, a theater, a hall, a bathhouse, or the inside of a vehicle; and bringing the particles into contact with SARS-CoV2 and / or influenza viruses suspended as aerosols to purify the air in the closed space.

11. The eluate is diluted with drinking water by a ratio of 10 to 4,000 times, then atomized into particles having an average diameter of 0.1 μm to 500 μm, and sprayed onto a part of the body, the skin side of a sanitary mask, or medical equipment in a medical setting to inactivate any attached novel coronavirus and / or influenza virus.

Citation Information

Patent Citations

  • Microbicidal sterilizer

    JP1995238004A